KC21 Peptide Inhibits Angiogenesis and Attenuates Hypoxia-Induced Retinopathy

In conclusion, KC21 peptide is an angiogenic inhibitor potentially useful for treating angiogenesis-related diseases.
Source: Journal of Cardiovascular Translational Research - Category: Cardiology Source Type: research